BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1788352)

  • 1. The effects of five new 17 beta-amino-estrogens, buame, endiame, etolame, picae, and procame on blood clotting time.
    Mandoki JJ; Rubio-Póo C; Lemini C; De la Peña A; Fernández JM; García-Mondragón J; Zavala E; Silva G; Mendoza-Patiño N
    Proc West Pharmacol Soc; 1991; 34():99-106. PubMed ID: 1788352
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrasting effects of estradiol and 17 beta-aminoestrogens on blood clotting time in rats and mice.
    Lemini C; Franco Y; Avila ME; Jaimez R
    Eur J Pharmacol; 2005 Mar; 510(3):229-33. PubMed ID: 15763247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on blood clotting time of 17 beta-estradiol and 17 beta-aminoestrogens in rats and mice.
    Jaimez R; Rubio-Póo C; Lemini C
    Proc West Pharmacol Soc; 2001; 44():163-6. PubMed ID: 11793970
    [No Abstract]   [Full Text] [Related]  

  • 4. Seasonal variations in blood clotting time in mice treated with an anticoagulant aminoestrogen.
    Rubio-Póo C; Silva G; Jaimez R; Lemini C
    Proc West Pharmacol Soc; 1998; 41():179-82. PubMed ID: 9836286
    [No Abstract]   [Full Text] [Related]  

  • 5. Estrogenic effects of 17 beta-aminoestrogens assessed in uteri of rats and mice.
    Lemini C; Franco Y; Avila ME; Jaimez R
    Eur J Pharmacol; 2005 Mar; 510(3):235-9. PubMed ID: 15763248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of rat blood clotting tests with reagents used for humans.
    García-Manzano A; González-Llaven J; Lemini C; Rubio-Póo C
    Proc West Pharmacol Soc; 2001; 44():153-5. PubMed ID: 11793967
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation and fibrinolytic studies on 17-beta-estradiol and synthetic estrogens.
    Astedt B
    Acta Obstet Gynecol Scand Suppl; 1977; 65():45-8. PubMed ID: 269625
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunomodulating effect of estrogens in different modes of administration].
    Kuz'menko VN; Bordiushkov IuN
    Patol Fiziol Eksp Ter; 1988; (2):62-4. PubMed ID: 3412811
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of combined synthetic progestins on blood coagulation properties and alpha 2-glycoprotein content].
    Lutsik LA
    Sov Med; 1981; (2):52-5. PubMed ID: 7244809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the time course of anticoagulant and estrogenic effects of prolame, butolame, pentolame and hexolame, a homologous series of 17 beta-amino estrogens.
    Rubio-Póo C; Lemini C; Silva G; García-Mondragón J; Zavala E; Castro D; Mendoza-Patiño N; Mandoki JJ
    Proc West Pharmacol Soc; 1993; 36():143-7. PubMed ID: 8378368
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biological activity of estrogens combined with progestagens in contraceptive preparations].
    Chruściel TL; Dudkiewicz J; Robel A; Suska T; Jurecka L
    Acta Pol Pharm; 1988; 45(1):92-6. PubMed ID: 3421141
    [No Abstract]   [Full Text] [Related]  

  • 12. Types of estrogen and delivery systems.
    Whitehead MI
    Postgrad Med; 1989 Apr; Spec No():78-83; discussion 89-90. PubMed ID: 2542912
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual effects of estrogens on blood clotting time.
    Mandoki JJ; Zavala E; Silva G; Mendoza-Patiño N; Rubio-Póo C; Medina-Martínez S; Domínguez-Escoto P
    Proc West Pharmacol Soc; 1983; 26():45-8. PubMed ID: 6310634
    [No Abstract]   [Full Text] [Related]  

  • 15. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of estrogens and estrogen-induced effects on nonreproductive organs and systems.
    Gorrill MJ; Marshall JR
    J Reprod Med; 1986 Sep; 31(9 Suppl):842-7. PubMed ID: 3772905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of an acidic sulfated polysaccharide on whole blood coagulability. In vivo study in rats].
    Caporiccio B; Braun M; Vignaud M; Chalet M; Codomier L; Teste J; Catayée G
    C R Seances Soc Biol Fil; 1984; 178(6):691-6. PubMed ID: 6242035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K-dependent blood clotting changes in female rats treated with oestrogens.
    Hart JE
    Thromb Haemost; 1987 Jun; 57(3):273-7. PubMed ID: 2821645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant and estrogenic effects of two new 17 beta-aminoestrogens, butolame [17 beta-(4-hydroxy-1-butylamino)-1,3,5(10)-estratrien-3-ol] and pentolame [17 beta-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol].
    Lemini C; Rubio-Póo C; Silva G; García-Mondragón J; Zavala E; Mendoza-Patiño N; Castro D; Cruz-Almanza R; Mandoki JJ
    Steroids; 1993 Oct; 58(10):457-61. PubMed ID: 8256254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal treatment of the menopause and vascular pathology].
    Rozenbaum H
    J Mal Vasc; 1984; 9 Suppl A():32-4. PubMed ID: 6330256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.